Oncologists welcome gene expression profiling tests for women with early-stage breast

[News]

Oncologists welcome gene expression profiling tests as an added tool in deciding whether women with early-stage breast cancer should have chemotherapy, a new study has found. But they have significant reservations about the cost of the test and whether it is being overused and used for the right patients.

More... (http://www.news-medical.net/news/20150309/Oncologists-welcome-gene-expression-profiling-tests-for-women-with-early-stage-breast-cancer-but-have-concerns.aspx)